PEDIATRICS Vol. 78 No. 6 December 1986, pp. 1170-1171
This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOHNSTON, K. M.
Right arrow Articles by MULVIHILL, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JOHNSTON, K. M.
Right arrow Articles by MULVIHILL, J. J.

Neuroblastoma in Duchenne Muscular Dystrophy

KATHREEN M. JOHNSTON MD1, SEYMOUR ZOGER MD1, MAHIN GOLABI MD1, and JOHN J. MULVIHILL MD2

1 Department of Pediatrics, University of California, San Francisco, CA
2 Clinical Epidemiology Branch, National Cancer Institute, Bethesda, MD

To the Editor.—

In reporting two patients with neuroblastoma and cystic fibrosis, Moss et al1 noted that "reports of cystic fibrosis and other genetic abnormalities in individual patients are usually regarded as chance associations."

We encountered an analogous situation in caring for a boy in whom stage III neuroblastoma developed at 9 months of age; he responded to surgery and chemotherapy and subsequently was found to have classical Duchenne muscular dystrophy at 3frac12 years of age.